TOKYO, May 25 (Pulse News Wire) – Abalance Corporation (3856.T) announced today that its 27th regular shareholders' meeting approved plans to reduce capital stock and capital surplus reserves. The reduction aims to enhance future capital policy flexibility and improve financial health.
Regarding the capital stock reduction, the company will decrease its capital stock from ¥2.521 billion to ¥500 million. Specifically, ¥2.021 billion will be reduced and transferred to additional paid-in capital. After the adjustment, the capital stock will stand at ¥500 million (pre-transfer amount was ¥2.521 billion), while additional paid-in capital will increase to ¥3.886 billion (pre-transfer amount was ¥0; transferred amount from capital stock is ¥2.021 billion; transferred amount from capital reserve is ¥1.865 billion).
For the capital surplus reserve reduction, the entire amount of ¥1.865 billion will be decreased, resulting in a post-reduction balance of ¥0. This amount will be transferred to additional paid-in capital. Following the transfer, the capital surplus reserve will be ¥0 (pre-transfer amount was ¥1.865 billion), and additional paid-in capital will rise to ¥3.886 billion (pre-transfer amount was ¥0; transferred amount from capital stock is ¥2.021 billion; transferred amount from capital surplus reserve is ¥1.865 billion).
Key dates for the process include: - Board resolution date: May 25, 2026 - Shareholders' meeting resolution date: June 24, 2026 - Notice publication date for creditors' objections: July 06, 2026 - Final deadline for creditor objections: August 06, 2026 - Effective date: August 12, 2026 The company expects the adjustments to have minimal impact on performance but will contribute to increased distributable earnings potential.
🟡 Confidence: Standard AI-translated content.